Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

22nd Alzheimer Europe Conference: Changing perceptions, practice and policy

The Commission Communication on a European initiative on Alzheimer`s disease ingled out four main areas for greater EU collaboration:

  • Acting early to diagnose dementia,
  • A shared European effort in research,
  • National solidarity and exchange of best care practices,
  • Respecting the rights of people with dementia.
Funding Programme
EU health
Start Date
End Date
Total Funding
€ 60 000
European Countries Involved

23rd AE Conference: Living well in a dementia friendly society

The Conference will organise an exchange of information and best practices on key aspects of the European Innovation Partnership on Active and Healthy Ageing in the fields of Integrated care, Prevention, Dementia friendly society and Innovative solutions.

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 80 000
European Countries Involved

24th AE Conference

The Conference is fully in line with the areas singled out in the Commission Communication on a European initiative on Alzheimer`s disease for greater EU collaboration, namely

1. Acting early to diagnose dementia,

2. A shared European effort in research,

3. National solidarity and exchange of best care practices,

4. Respecting the rights of...

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease

NILVAD

Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even...

Funding Programme
EU-FP7
Start Date
End Date
Total Funding
€ 7 916 016

A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's Disease

FluiDx-AD

FluiDx-AD aims to transform Alzheimer’s disease (AD) diagnosis and prepare the EU healthcare systems for the emergence of new AD therapies, with a 1st-in-class trio of In Vitro Diagnostics tests.FluiDx-AD tests detect a unique and proprietary suite of biomarkers in simple bodily fluids (saliva, plasma/blood), towards widespread, patient-empowering...

Funding Programme
EU-Horizon Europe
Start Date
End Date
Total Funding
€ 7 699 219
European Countries Involved

Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification

PREDICTFTD

Frontotemporal dementia (FTD) has a debilitating effect on patients and their caregivers and leads to substantial economic costs. 15-30% of patients have familial FTD caused by known pathogenetic mutations. For the other 70-85% of patients, termed sporadic FTD, diagnosis is slow (~3.6 years) with frequent misdiagnosis due to clinical, genetic and...

Funding Programme
EU-Horizon Europe
Start Date
End Date
Total Funding
€ 7 994 911

Aetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy

AETIONOMY

IMI’s Call 8 is geared to develop knowledge frameworks for ‘druggable mechanisms’ for two domains of pathophysiology. In response to this call, we propose (I) the development of a generic AETIONOMY pipeline to capture and infer over mechanistic knowledge of pathophysiology, and  (II) the focused application of this pipeline to derive clinically...

Funding Programme
IMI
Start Date
End Date
Total Funding
€ 17 546 060

AE_FY2013

Alzheimer Europe (AE) defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment options and care services". In addition, the organisation has defined its guiding philosophy as "promoting the autonomy and self-determination of people with dementia and their...

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 190 000
European Countries Involved

AE_FY2014_FY2013

Alzheimer Europe (AE) defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment options and care services". In addition, the organisation has defined its guiding philosophy as "promoting the autonomy and self-determination of people with dementia and their...

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 285 168
European Countries Involved

Alzheimer Europe (2015-2017)

The 2015-2017 framework programme of Alzheimer Europe aims to achieve the following objectives:

1. Increasing knowledge about current national dementia policies and strategies, in order to promote best practices and reduce inequalities in dementia care in Europe (dementia-friendly communities, legal capacity and proxy decision making, care...

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 422 880
European Countries Involved

Alzheimer Europe (2015-2017)

The 2015-2017 framework programme of Alzheimer Europe aims to achieve the following objectives: Increasing knowledge about current national dementia policies and strategies, in order to promote best practices and reduce inequalities in dementia care in Europe (dementia-friendly communities, legal capacity and proxy decision making, care standards...

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 422 880
European Countries Involved

Alzheimer Europe - AE FY 2011

Alzheimer Europe defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment options and care services". To achieve its mission, Alzheimer Europe has defined the following six objectives in its strategic plan which covers the period of 2006-2010:Representing...

Funding Programme
EU health
Start Date
End Date
Total Funding
€ 200 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).